Reach patients in your indication.
Bring relevant condition audiences to the free mama health app through indication and market campaigns.
Your indication. Your market.MAMA HEALTH FOR BAYER PHARMACEUTICALS
From prostate cancer to cardio-renal care, every patient journey brings different barriers. Reach relevant patients, give them useful support, and learn what shapes their treatment decisions.
Data tells you what happened. Patients tell us why.
Trusted by
life science teams
YOUR TEAM. YOUR PATIENT QUESTION.
BRAND & MARKETING
Hear the questions, concerns and language that shape whether patients seek information or support.
What stops patients bringing up symptoms and asking for help?
Use their perspective to focus campaign messaging, education and support.
Illustrative questions across Bayer’s portfolio. Patient coverage is confirmed for each indication and market.
FROM PATIENT REACH TO PATIENT INTELLIGENCE
Connect patient reach, useful support and continuous patient intelligence.
Bring relevant condition audiences to the free mama health app through indication and market campaigns.
Your indication. Your market.Help patients understand their condition, ask questions and prepare for appointments. Measure the next action they take.
Patient value. Measurable actions.Turn consented conversations into anonymized, aggregated intelligence, supported by medical and scientific review.
Patient reasons. Continuously updated.INDICATION AND MARKET COVERAGE
A patient journey changes from one market to the next. Understand the local questions, treatment expectations and barriers behind your indication strategy.
Conversations in patients’ own language, grounded in how they navigate care where they live.
Check your indicationPatient coverage varies by indication and market. We’ll confirm the relevant cohort for your question.

WHAT OUR CLIENTS SAY
By working with mama health, we can integrate the unbiased patient perspective into our business strategy, unlock actionable insights and continuously measure the impact of our initiatives.
BEFORE WE TALK
Coverage depends on the indication and market. We’ll check the available cohort and evidence for your question, explain any limitations and discuss targeted patient reach or research if more evidence is needed. The portfolio examples on this page are discussion areas, not confirmed dataset availability.
Claims, prescription and market data can show patient behavior. Direct conversations add the reasons and experiences patients describe. Use that perspective alongside your existing datasets, research and clinical evidence.
Yes. Brand, business insights, medical affairs, market access and patient support teams bring different questions to the same patient journey. We define the question, cohort and intended use together before scoping the work.
Conversations are anonymized and aggregated for analysis with consent. AI-supported structuring is supported by medical and scientific review. We explain source context, sample sizes, recruitment and limitations so your team can judge what a finding supports. We also review project-specific data governance and pharmacovigilance requirements during scoping.
PUT PATIENT PERSPECTIVE INTO YOUR NEXT PLAN
Share your indication, market and team. We’ll confirm what patient intelligence is available and discuss how it can inform your next launch, campaign or support decision.
If your indication needs more evidence, we’ll explain the options for patient reach or research.
Select your team, market and indication. Then choose a meeting time.
Loading available times…
Can’t see the calendar? Continue on the booking page.